Evidence map›Paper›PMID 36982420›Full record

ArticleInternational journal of molecular sciences2023

Activation of TLRs Triggers GLP-1 Secretion in Mice.

Lorène J Lebrun, Alois Dusuel, Marion Xolin, Naig Le Guern, Jacques Grober

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. The Effect of Enteric-Derived Lipopolysaccharides on Obesity.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lorène J LebrunINSERM LNC UMR1231, Université de Bourgogne, 21000 Dijon, France.ORCID 0000-0002-4486-9723
Alois DusuelINSERM LNC UMR1231, Université de Bourgogne, 21000 Dijon, France.
Marion XolinINSERM LNC UMR1231, Université de Bourgogne, 21000 Dijon, France.
Naig Le GuernINSERM LNC UMR1231, Université de Bourgogne, 21000 Dijon, France.
Jacques GroberINSERM LNC UMR1231, Université de Bourgogne, 21000 Dijon, France.ORCID 0000-0003-0503-4819
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gastrointestinal tract constitutes a large interface with the inner body and is a crucial barrier against gut microbiota and other pathogens. As soon as this barrier is damaged, pathogen-associated molecular patterns (PAMPs) are recognized by immune system receptors, including toll-like receptors (TLRs). Glucagon-like peptide 1 (GLP-1) is an incretin that was originally involved in glucose metabolism and recently shown to be rapidly and strongly induced by luminal lipopolysaccharides (LPS) through TLR4 activation. In order to investigate whether the activation of TLRs other than TLR4 also increases GLP-1 secretion, we used a polymicrobial infection model through cecal ligation puncture (CLP) in wild-type and TLR4-deficient mice. TLR pathways were assessed by intraperitoneal injection of specific TLR agonists in mice. Our results show that CLP induces GLP-1 secretion both in wild-type and TLR4-deficient mice. CLP and TLR agonists increase gut and systemic inflammation. Thus, the activation of different TLRs increases GLP-1 secretion. This study highlights for the first time that, in addition to an increased inflammatory status, CLP and TLR agonists also strongly induce total GLP-1 secretion. Microbial-induced GLP-1 secretion is therefore not only a TLR4/LPS-cascade.

Indexed as

LipopolysaccharidesToll-Like Receptor 4Adjuvants, ImmunologicAnimalsGlucagon-Like Peptide 1MiceMice, Inbred C57BLToll-Like ReceptorsAdjuvants, ImmunologicGlucagon-Like Peptide 1LipopolysaccharidesToll-Like Receptor 4Toll-Like Receptorscecal ligation punctureglucagon-like peptide 1inflammationpolymicrobial infectiontoll-like receptors

Identifiers

PMID36982420
PMCPMC10049702
OpenAlexW4324094637

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read19
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.